A B S T R A C T The present data disagree with earlier suggestions that thrombin's effect on platelets is to cause a decrease in intracellular cyclic 3',5'-adenosine monophosphate. Washed humani platelets or plateletrich plasma were incubated at 37°C with human thrombin. After centrifugation, the supernates were assayed for nucleotides and calcium released. The platelet pellets, anid in some experiments the supernates as well, were assayed by radioiimmunoassay for intracellular cyclic AMP. In the washed platelet systenm, increasing doses of thrombin to 0.5 U/cc induced increasing release of nucleotides and calcium. This was accompanied by an average twofold increase in intracellular cyclic AMP levels. Prostaglandin E1, which inhibited 30-50% of release, induced a four-to fivefold increase in cyclic AMP levels that was additive to the cyclic AMP-stimulatory effect of thrombin. Theophylline. which inhibited only 20-40%4 of nucleotide release, was synergistic with thrombin in the intracellular accumulation of cyclic AMP. The timiie-course of cyclic AMP accumulation in response to thrombinl was slower thani thrombin-induced nucleotide release. Similar findings were made in the platelet-rich plasma system where thrombin stimulation of nucleotide release also resulted in a marked accumulation of intracellular cyclic AMP. Thrombin did not appear to stimiiulate the release of intracellular cyclic AMP.
A B S T R A C T The present data disagree with earlier suggestions that thrombin's effect on platelets is to cause a decrease in intracellular cyclic 3',5'-adenosine monophosphate. Washed humani platelets or plateletrich plasma were incubated at 37°C with human thrombin. After centrifugation, the supernates were assayed for nucleotides and calcium released. The platelet pellets, anid in some experiments the supernates as well, were assayed by radioiimmunoassay for intracellular cyclic AMP. In the washed platelet systenm, increasing doses of thrombin to 0.5 U/cc induced increasing release of nucleotides and calcium. This was accompanied by an average twofold increase in intracellular cyclic AMP levels. Prostaglandin E1, which inhibited 30-50% of release, induced a four-to fivefold increase in cyclic AMP levels that was additive to the cyclic AMP-stimulatory effect of thrombin. Theophylline. which inhibited only 20-40%4 of nucleotide release, was synergistic with thrombin in the intracellular accumulation of cyclic AMP. The timiie-course of cyclic AMP accumulation in response to thrombinl was slower thani thrombin-induced nucleotide release. Similar findings were made in the platelet-rich plasma system where thrombin stimulation of nucleotide release also resulted in a marked accumulation of intracellular cyclic AMP. Thrombin did not appear to stimiiulate the release of intracellular cyclic AMP.
The mechanism underlying these observations was not apparent. The thrombin had no measurable inhibitory effect on platelet phosphodiesterase activity in either intact washed cells or the platelet homogenate supernates. Furthermore, thrombin inhibited, rather than stimulated, platelet adenyl cyclase activity in both 
INTRODUCTION
In recent years, several investigators have implicated cyclic AMP as a factor in the control of normal platelet function (1, 2) . Incremenits in cyclic AIMP levels have been observed in response to various agents that inhibit p)latelet aggregation (3) (4) (5) . Conversely, some agents which stimulate or augment platelet aggregation have been associated with reduced cyclic AMP levels (1, 2, 6, 7) . This has led to the concept that the antagonistic actions of various substances on platelet function may be mediated by opposite effects on cyclic AMP concentrations.
The results of the present study dlo niot support this concept. Washed humiani plaltelets were found to react to human thrombini bv accumulatiing inicreased intracellular levels of cyclic AMP rather than the decreased levels others have reported. This increase was observedl with amounts of thrombin previously shown to induce platelet aggregation (8) . The increase occurred in conjunction with the release of platelet nucleotides and calcium into the surrounding medium, a process thought either to precede or accompany platelet aggregation (9) . The present study thus stresses the need for further evaluation of the biochemical events that characterize and determine platelet function as well as the role of cyclic AMP as a possible physiological determinant of normal platelet activity.
METHODS
Freshly drawn blood from normal male subj ects without (drug exposure was anticoagulated with a 10% solution of EDTA (0.15 cc per 10 cc blood) and cooled to 4°C. \Vashed platelets were obtained as previously described (10) aind resuspended in a 25 mm Tris-HCl buffer, pH 7.4, containiing 140 mm NaCl and 0.3 mm EDTA.
Duplicate portions of the washed platelet suspensions, containing 700,000-1,500,000 platelets per mm', were kept either at 4°C or preincubated at 37°C for 5 min. For doseresponses studies, human thrombin (provided by Dr. D. Aronscn, Division of Biologic Standards, National Institutes of Health), ranging between 0.0625 and 1.0 U/cc final incubation concentration, was added to the plate'ets and incubation continued for 5 min. The time-course of thrombininduced nucleotide and calcium release was studied by incubating platelet suspensions with 0.25-0.50 U/cc of thrombin at 37°C for times varying between 5 sec and 5 min.
Theophylline (from Matheson, Coleman and Bell, Cincinnati, Ohio), 3.0 X 10-' M final concentration, or prostaglandin E1 (from Dr. J. Pike. The Upjohn Company, Kalamazoo, Mich.), 3.0 X 10-' M final concentration, was added to some tubes before initial incubationl. Appropriate controls at 4 and 37°C with or without thrombin, prostaglandin, and theophylline were run concurrently in each experiment.
After incubation, all samples were cooled to 4°C to stop the release reaction and spun at 2250 g for 15 min.
Similar studies were performed using citrate (0.1 cc of 10% Na citrate in normal saline per 10 cc blood) and normal saline rather than an EDTA-anticoagulated system. Experimental procedures and materials were otherwise identical to those already described.
Supernates were added to 2.5 M perchloric acid (0.5 AI final concentration) and the total nucleotide content read at 260 mA on a Beckman spectrophotometer (Beckman Instruments, Inc., Fullerton, Calif.) (11) . These portions were then diluted 1: 2 with 0.15 M lanthanum chloride and assayed for calcium content on a Perkin-Elmer 303 atomic absorption spectrophotometer (Perkin Elmer Corp., Norwalk, Conn.) (12) . In some experiments, a portion of the supernate was also assayed for cyclic AMP content as described below together with the platelets from the same samples.
Platelet pellets were kept at 4°C. Their cyclic AMP was extracted by a modification of procedures described by Steiner Cyclic AMP concentrations were determined by a modification of the radioimmunoassay procedures developed by Steiner et al. (13) . The 2'0-succinyl tyrosine methyl ester of cyclic AMP was synthesized and iodinated with 'I to prepare the cyclic AMP tracer (ScAMP-'I).' Antibody to cyclic AMP (ScAMP-Ab) was produced by injecting human serum albumin succinyl cyclic AMP in Freund's adjuvant intradermally into rabbits at 2 to 4-week intervals and harvesting the serum at 4 6 wk.
The radioimmunoassay incubation system, in a final volume of 500 Al, contained 5-10 x 10' cpm of the ScAMP-'"I After incubation, 1.5 cc of a 16% polyethylenie glycol solution containing 0.8 mg/ml bovine gamma globulin was added to each incubation mixture to precipitate the cAMP-antibody complex (14) . The portions were centrifuged at 2200 g for 1 hr, the supernates were discarded, and the tubes allowed to drain for at least 2 hr. The samples were counted for 'I in a Packard 5022 gamma counter (Packard Instrument Co., Inc., Downers Grove, Ill.). Samples for total counts, background, total binding, and a semi-logarithmic standard curve with a range of 0.4-204.8 pmoles cyclic AMP were prepared for each assay. Separate experiments were done to confirm the identity of the substance being assayed as cyclic AMP, according to the methods of Aurbach and Houston (15) . Washed platelets, which had been incubated for 5 min at 37°C with thrombin (0.5 U/cc), were sonicated at 4C as above and then heated at 105°C for 3 min to destroy endogenous phosphodiesterase activity (16) . After cooling, samples were incubated at 37°C for 20 min with active beef heart phosphodiesterase (PDE) purified according to Butcher and Sutherland (17) , boiled exogenous PDE, or buffer. Trichloroacetic acid was then added to each portion and the samples were centrifuged, extracted, lyophilized, and assayed for cyclic AMP together with the specimens above.
Because of the differences between the results obtained in the present washed platelet system and data reported in previous studies using platelet-rich plasma (2) (3) (4) , further experiments were performed using platelet-rich plasma anticoagulated with EDTA, maintained at 37'C and exposed either to buffer or thrombin. Other portions of platelet-rich plasma were kept at 4°C. After a 5 min incubation, the platelet-rich plasma was centrifuged at 2200 g for 10 min. The resulting platelet pellets and the platelet-poor plasma were separately extracted and assayed for cyclic AMP as described above.
In an attempt to determine the mechanism of action of In the presence of prostaglandin E, which alone causes a four-to fivefold increase in cvclic AAIP, the stimulatory effect of throlmibin al)l)ears to be slightly w(l(ditive (Fig. 3 ) . In contrast. tlirolhibn together-with 
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CONTROL THROM CONTROL THROM THROM THOMM PGE, THEO FIGURE 2 Effect of thrombin, prostaglandini E, and theophyllinie on the platelet release reactioni The per cent of total nucleotide and calcium release in response to thrombini (0.5 U/cc), prostaglanidin E1 (3 X 10' I), and/or theophylline (3 X 10' M) is given as the mean of 10 different determinations +1 s5).
theophylline induce a synergistic increase in intracellular platelet cyclic AMP levels (Fig. 3) . Similarly, in the dose-response studies the presence of theophylline amplifies the amount of cyclic AMP accumulated in response to each dose of thrombin tested (Fig. 1) . The linearity of the dose-response relationship with concentrations of thrombin up to 0.25 U/cc is maintained.
The time-course of the release reaction of washed platelets in response to thrombin is extremely rapid.
At least 50-60% of the release of nucleotides and calcium is complete within 5 sec of incubation with thrombin (0.5 U/cc) (Fig. 4) . At least 80-90% of release has occurred by 15 sec. By' 30 sec, the total amount of releasable nucleotides and calcium, amounting to approximately 60% of the platelet's total content of these substances (20) , appears in the extracellular medium. Incubation to 5 min does not change these levels.
In these time-course studies, cyclic AMP accumulation in response to thrombin seems to be slower than the release of nucleotides and calcium (Fig. 4) . cyclic AMP, however, are maintained in all of the platelet samples. Furthermore, the release of calcium and nucleotides in response to thrombin occurs to the same extent as in the EDTA-anticoagulated system.
In the plasma system the effect of thrombin is even more striking than in the washed platelet preparations (Table I) . At 4°C, base line levels are similar to the cyclic AMP concentrations observed in the washed platelet systems described above. These levels are also comparable to cyclic AMP levels seen in plasma platelets maintained at 37°C. The addition of thrombin to these platelets at 37°C induces a twofold and as great as a fourfold increase in cyclic AMP levels. The use of sonication before the addition of TCA in the cyclic AMP extraction procedures does not seem to alter the basic phenomenon observed in the present investigation. Extracellular plasma concentrations of cyclic AMP in the same experiments are high enough (150-200 pmoles/cc) to prevent an interpretation of small changes in extracellular cyclic AMP levels in response to thronmbin. The effect of citrate in the plasma medium was not evaluated.
If the increase in radioimmunoassayable material which occurs with thrombin in either the washed or the plasma system is indeed cyclic AMP, it would be predicted that exposure to endogenous or exogenous phosphodiesterase (PDE) would eliminate this increment. Washed platelets heated to 95°C to destroy endogenous PDE (16) when incubated with either buffer or boiled exogenous PDE, maintain the cyclic AMP levels accumulated in response to thrombin (Fig. 6 ).
Incubation with active exogenous PDE destroys the increments that thrombin induces. Prolonged incubation at 37°C of platelets not preheated, allows endogenous platelet PDE to destroy the increased cyclic AMP levels that occur with thrombin. In fact, the 20 min of incubation reduces these levels to half base-line. As previously reported in other tissues (15) , this establishes the identity of the substance being assayed as cyclic AMP.
Particulate fractions obtained from platelets exposed to thrombin have less than half the basal activity of adenyl cyclase compared to platelets incubated without thrombin (Table II A) . Similarly, the stimulation of platelet cyclase activity by prostaglandin E1 added to these preparations is less than half as great as in prostaglandin-stimulated control platelet particulate fractions. It is important to note, however, that the stimulation of cyclase activity by prostaglandin in these experiments is not completely inhibited by the previous exposure to thrombin. Rather, there is still an 8-to 10-fold increase in cyclase activity in response to the exogenous PGE1, despite the presence of the active thrombin (0.25-0.50 U/cc). Moreover, the stimulation of enzyme activity by NaF is only mildly depressed by prior incubation of the intact platelets with thrombin. Similar changes have also been seen by other investigators (8) .
The addition of thrombin (0.5 U/cc) to the cyclase assay incubation mixture itself also has a major effect on adenyl cyclase activity (Table II B) . Basal activity is depressed by 60%. Prostaglandin-stimulated activity, however, is inhibited by only 40%. As in the intact platelets, all of the PGEi-stimulated activity is not abolished by simultaneous exposure to thrombin. Cyclase activity is still increased to 8 times basal levels. Furthermore, NaF-stimulated enzyme activity is again only mildly depressed. No effect oni normal phosphodiesterase activity is apparent in platelets incubated while intact with thrombin. Similarly, platelet homogenates assayed for phosphodiesterase activity in the presence of thrombin appear to have no alteration in enzyme action compared with control platelets.
DISCUSSION
Results of the present stud) raise questions about the commonly-held view that stimulation of platelet function is mediated by a lowering of intracellular cyclic AMP. At concentrations of thrombin that cause maximal release of nucleotides and calcium from platelets. and are known to cause complete platelet aggregation, there occurs at least a twofold increase in platelet cyclic AMP levels both in washed platelet preparations and platelets from platelet-rich plasma. This increase lags by several seconds the occurrence of nucleotide and calcium release.
Several questions are posed by these data. First, what explanations are there to account for the discordance between results in the present study, describing a thrombin-induced increase in intracellular cyclic AMP, and the generally-accepted hypothesis that aggregating agents work by lowering platelet cyclic AMP content? (1) . However, the base line levels of cyclic AMP in the washed platelets were similar to those of platelets kept in plasma and not subjected to repeated centrifugation, both in the present study (Table I) and in work previously reported by Cole, Robison, and Hartmann (21) . Furthermore, in each experiment duplicate portions at 4 and 37°C with and without thrombin and/or theophylline were always run to validate the increase in cy-clic ANIP observed in response to thromiibin. The presence of these controls in each experiment appeared to nullify the possible decremental effect of centrifugation that otherwise might perhaps have obscured the phenomena being reported.
In order to study the activity of various platelet enzvmiles in our washed preparationis, as wsell as the effects of time aind tlhromlbin (lose onl the release reaction and the accumulation of cyclic AMP,1' the lplatelets in the present investigation wevre kept chilled at 4°C when not heing incubated. Such chillilng has also beenl relported to effect l)latelet cyclic AAI11 levels ( 1 ). As w\as true in the case of centrifugationi, however, the internal controls in eaclh experiment in the lpresenlt Nvork l)ermitted reliable observations of the stimitulatorv effect of thrombin on cyclic AMP levels since all of the samples had been chilled. Moreover, chillinig seemed to have no effect on the base line cyclic AMIP levels; nor did it decrease the prostaglandin-stimulated cvclic A XI P increments also reported by others (2, 4) .
Procedures used to extract pllatelet cyclic AMIP were basically similar to mletlhods described for use with platelets (1, 22) as well as otlher tissues (13) . The only major change was the use of sonicatioln in order to studv the enzvyme activities in the various saimiples.
However, this seellmed to have 110 effect on1 cyclic AMIP levels (Table I) . lpresumlalbly because the l)rocedures wvere conducted at 4°C tlhrouglhout, preventing thereby any sonication-stimulate(I activity of inhibitory or stimulatory enzymes. Similarly, the radioimmunoassav techniques used in the present work hald already been welldescribed and reliably used in other cell types (13, 23) . These procedures provide(l reproducible results in the present study as well, both in the washed platelet systeml and in platelet-rich plasma. The validity of these results as being truly representative of the changes in platelet cyclic AMP described above was shown by destroying the thrombin-iniduce(d cyclic AMP incremlents with exogenous beef heart pllosplhodiesterase ( Fig. 6 ), using nmethods previously employed ill otiler tissues (15) .
As a final check on the reality of the l)henollmellon observed in the washed platelet system, however, the same experiimlental and radioimmunoassay procedures were applied to the platelet-rich plasma system used in previous investigations. The results obtained (Table I) .
were again in conflict with the hypotlhesis suggested by earlier workers. The thrombiii wvas repeatedly found to induce at least a twofold increase in intracellular cyclic ANIP. 'Moreover, base line concentrations of cyclic AMP were comeparable to those observed in the washed platelet systemii.
Such data suggest that the plhenonlenoll described in the present study was not necessarily due to methodological artifact. This coinclusionl, however, pro1mpted a search of earlier investigations for possible reasons to explain the discrepancies reported. Several possible explanations were uncovered by such a review.
The conceptual role of cyclic AMP as a possible miiediator of platelet fuinctioln was first suggested by studies thlat dlocunlente(l tlle stimulation of cyclic A 1 P levels 1y l)rostaglanllin E, an inhibitor of l)latelet aggregationl (2) (3) (4) 24) . Similar p)latelets, with intracellular cyclic AMP levels already elevated 1y prior exposure to prostaglandin ET, were tlheni incubated witlh one of thle aggregating agents ( 2, (6) . This resuilted ill a (lecrease in the prostaglan(lin-elevated cy-clic AMP1 concentrations. The interpretation of these dlata ledI to the 1h-pothesis that aggregatinig anid iinhibiting substances exert their opposing effects on platelet function througl opposite effects on platelet cyclic AMP.
In these studies the effect of prostaglandin on stinmulating greater cyclic AMIP production was fairly straightforward. However, the effect of the releasing agents on decreasing cyclic AMIP levels was based oln evidence somewhat less direct, since the effects of these agents on base line levels of cyclic AMIP were not assessed. The more direct evidence in the preseilt illvestigation, testing thronmbin alone oil base line cyclic AAMP concentrations, as well as recent reports b1 Haslam and Taylor (25) describing anl ep)inephrine-induced increase above base line in platelet cyclic ANIP levels after incubation of platelet-rich plasma witlh epinephrine alone, strongly challenge this hypothesis.
In addition, several differences of nmethodology may hiave led to the discordalnce of results being discussed. For exanlple, in otlier investigatiolls ilncubation times usually were long, at least 15 to 20 miiin. During this tillle, endogenous l)latelet phosphodiesterase could hlave destroyed any increase in cvclic AMPIP that hlad occurred in response to the aggregating ageilt. Tilis, in fact, was seen in the present studv wlien plaltelet homiiogenates illcubated with buffer for 20 min at 37°C after tile initial 5 niin experinlental incubation with or without tllrolllbin displayed half-base line or lower levels of cyclic AMP (Fig. 6) . A somewilat silililar finding wvas reported by Haslanii anld Taylor wlho described an accumulation of cyclic AMIP in platelets in response to epinel)llrille during the 1st mnin of illcubationl and anl inhibition of this accuillulatioll during the 2nid illin (25 Seconid, thrombin was founid to lhave a l)ronouncedl stillulatory effect on cyclic AMP levels even in the plasma system when EDTA was the anticoagulant (Table I) in contrast to findings in previous studies where citrate was used (2, 3, 6 (26) . On this basis, subsequent investigators found that nornmal platelet function is effected by a delicate balance between Mg++ and Ca"4 and that in vitro this balance is governed by the type of anticoagulant used in the system (27) (28) (29) . Further insight was provided by the finding that the balance between Mg`+ and Ca++ is critical in determining the activity of adenyl cyclase in other tissues (19, 30) . In these studies, as well as in platelets in the present work, 10-M Ca++ partially inhibited and 102 M Ca++ completely inihibited PGE1-and NaF-stimulated adenvl cvclase activity. MIoreover, in previous studies using washed platelet prel)arations (10) , just the use of citrate in preventing platelet clumping was found to be enough to prevent the striking stimulatory effect of PGE, on adenyl cyclase activity that was seen when EDTA was used instead. Such inhibition of cyclase activity, just by varying the Ca++ concentration, or more simply by changing the cation chelator, may have been adequate in the previous studies (2. 3, 6) to prevent cyclic AMP formation. Use of the mlore powerful chelating agent EDTA (26, 27) as the anticoagulant in both the washed platelet system as well as in the platelet-rich plasma in the present work nmay have circumvented this inhibition and allowed the stimulation of cyclic AMP that was observed.
How does thromibini stimiiulate cyclic AMP acctumulation-? Conceivably, the thrombin-induced accumulation of intracellular cyclic AMP might have been the result of decreased cyclic AMP release from cells because of exposure to thrombin. Data in the present study did not support this concept. Base line levels of extracellular cyclic AMP were less than 0.4 pmoles/109 platelets. The presence of theophylline in the bathing nmedium to inhibit any exogenous phosphodiesterase activity over the 5 min incubation time did not alter the amount of cyclic AMP found extracellularly. This would argue against the possibility that cyclic AMP is released constantly from platelets so as to inhibit aggregation and that thrombin, by interfering with this release, produces an increased intracellular cyclic AMP level.
For the most part, the increased levels of cyclic AMP observed in response to various substances in other cell types have been found to be due to either a stimulation of adenvl cyclase activity anld the production of cyclic AMP or anl inhlibitioni of phospliodiesterase activit) and the decreased destruction of cyclic AMIP. In the present study, both of these possibilities as well were examined. First, human thromiibin was shown to have no measurable effect on platelet phosphodiesterase activity in supernatant fractions from platelet homogenates. Similarly, Brodie, Baenziger, Chase, and Majerus could not demonstrate any inhibitory effect (8) . Such studies suffer from their inability to deternmine phosphodiesterase activity within the actual cell and its compartmlents. However, the data at hand suggest that the elevations in cyclic AMP did not result from an inhibition of cyclic AMP destruction.
The synergistic effect of thrombin on platelet cyclic AMP with theophylline, a phosphodiesterase inhibitor (24) , suggested that the action of thrombin on the accumulation of cyclic AMP might be mediated by a stimulation of adenyl cyclase. It was found, however, that thrombin added either to intact washed platelets before assaying thenm for cyclase activity or to washed platelet homogenates during the cyclase assay inhibite(d rather than stimulated adenyl cyclase activity (Table   II) .
These results were simiilar to those of earlier studies that also described an inhibition of cyclase activity by bovine thrombin (31) (32) (33) . i'Iore recent work by Brodie et al., using human thrombin, also demonstrated an inhibition of cyclase activity in intact platelets by as little as 0.1 U/cc, a level comparable to that used in the present investigation. Moreover, the thrombin in these studies had its greatest effect on prostaglandin-stimulated cyclase activity, a phenomenon that was also seen to occur in the present work. The two sets of data differed in the effect of thrombin on sonicated platelet homogenates: the present data demonstrated marked inhibition of both base line and prostaglandin-stimulated cyclase activity in washed platelet particulate fractions; data from the work of Brodie et al. did not detect any inhibition. At present, we cannot reconcile or explain the differences. In any event, a direct effect of thrombin in stimulating cyclase activity to explain the increments of cyclic AMP observed could not be demonstrated. Indeed, the opposite seemed to be true.
However, further analysis of the data disclosed that perhaps an indirect effect by thrombin could have stimulated cyclase activity. In the assays for adenyl cyclase, prostaglandin E1 was found to stimiiulate enzyme activity 15-to 18-fold. The addition of thrombin to the assay incubation medium, or the prior addition of thrombin to intact platelets, seemed to inhibit the prostaglandin-stimulated activity by 40-50%. Thus, prostaglandin-stimulated activit) was not completely abolished; an 8-to 10-fold inicrease in activity above base line was still apparenit. Evidently, the aiimount of human thrombin used, presumably a physiological level (8),
was not enough to override completely the effect of PGE1 in the present study. This is significant, for recent investigations have reported that thrombin induced human platelets to produce and release prostaglandins E2 and F2. (34) . In human Iplatelets, both of these prostaglandins in high enough concentrations may be capable of stimlulating adenyl cvclase (10) and the formation of cyclic AMIP. This stimiulatory effect in vivo might override the direct inhibitory effect of thrombin on cyclase activity seen in vitro and explain the phenomenon of a thrombin-induced increase in intracellular cyclic AMP observed in the present investigation.
In any case, the mechanislm by wvhich thrombin induced the accumulation of cyclic AMIP in platelets in the present investigation remaiined conjectural. This is not a situation without precedent. Recent studies of the effect of triiodothvronine (T: ) in increasing cyclic AMP levels in fat cells could not document the meanis by which this occurred (35) . The investigators (lid not consider the possibility that the T. might stimulate prostaglandin production. In a somewhat different investigation, an inhibitor of glucagon-stimulated cyclase activity was found in the cytoplasm of hepatocytes (36) . The possible presence of a similar inhibitor in platelets could account for the absenice of thromibin effect observed in the in vitro systemis used in the present study.
What is the role of cyclic AMP in platelet function? Results in the present study clhallenge the hypothesis that a decrease in intracellular cyclic AMIP is the factor that mediates platelet aggregcation. The data indicate, rather, that we may be dealing wvith a spectrum of cyclic AMP accumiiulation in response to various agents with opposite effects on platelet activity. At the one end. aggregating agents such as thrombin in the present study and epinephrine in the report by Haslam and Taylor (25) , induce the accumulation of small amounts of cyclic ANIP, perhaps by stimulating the production and release of prostaglandins from the cells. At the other end, exogenous prostaglandin E1, a potent inhibitor of platelet aggregation in vitro, stimulates the production of greater amounts of cyclic AMP.
If we assume that we are dlealiing w\ith a homiiogeneous platelet population, as seenms to be the case from morphological studies,2 the cyclic AMIP accumulatecd in response to thrombin in the present investigation may be a manifestation of several possible occurrences. For one, the cyclic AMP may in some way be involved with the secretory processes associated with the platelet release reaction. In other cell types, substances that stimulate cell secretion also have been found to increase the 'Droller, M. J. Ultrastructural study of the effects of aggregating agents and their inhibitors onl the platelet release reaction. In preparation. cellular content of cyclic AMP' (37) . A second possibility is that the elevations in cyvclic AMP may be a nonspecific response to various agents and have nothing to do with controlling or nmediating the process of aggregation at all. This possibility has been suggeste(d independently by Boullin, Green, and Price (38) in their recent studies on ADP-induced l)latelet aggregation.
The third, and most intriguing possibility, involves l)ostulation of a feedback mechanism of platelet function. Here, the accumulation of cyclic AMP in response to low-dose thrombin may represent an attempt by the platelet to make the aggregating process reversible.
At present, such postulations must remain conjectural. Any additional hypotlhesis as to the mechanism of action of thrombin, prostaglandins, and cyclic AMP as physiological determinants of normal l)latelet function must await further investigation.
